<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Evaluation of clinical, demographic and epidemiologic features of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and therapy response of these patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODOLOGY: Retrospectively, 116 patients (64.7% female) were enrolled in this study </plain></SENT>
<SENT sid="2" pm="."><plain>Mean age and mean follow-up period were 36+/-16, 5+/-2 years, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The most common anatomic involvement was <z:e sem="disease" ids="C0868908" disease_type="Disease or Syndrome" abbrv="">pancolitis</z:e> (60.3%) and the others were as follows: left side 25%, rectum 13.8% and ileum (backwash <z:mp ids='MP_0009482'>ileitis</z:mp>) 0.9% </plain></SENT>
<SENT sid="4" pm="."><plain>Extraintestinal manifestations were observed in 42.2% of patients (<z:e sem="disease" ids="C0574960" disease_type="Disease or Syndrome" abbrv="">sacroiliitis</z:e> 12%, primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> 7.6%, <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum 2.4%, peripheral <z:hpo ids='HP_0003040'>arthropathy</z:hpo> 1.6%, autoimmune <z:hpo ids='HP_0012115'>hepatitis</z:hpo> 1.6%, <z:hpo ids='HP_0001397'>steatosis</z:hpo> 12.9%, <z:mp ids='MP_0002830'>gallstone</z:mp> 0.8%, perianal <z:mpath ids='MPATH_70'>fistulas</z:mpath> 0.8%, sagittal sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> 0.8%, <z:hpo ids='HP_0003765'>psoriasis</z:hpo> 0.8%) </plain></SENT>
<SENT sid="5" pm="."><plain>Multiple extraintestinal manifestations were observed (primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> + <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum) in 2 patients </plain></SENT>
<SENT sid="6" pm="."><plain>Colonic <z:mpath ids='MPATH_81'>perforation</z:mpath> due to toxic <z:hpo ids='HP_0002251'>megacolon</z:hpo> was observed in only one patient during follow-up period </plain></SENT>
<SENT sid="7" pm="."><plain>The mean period for remission was 3.7 months in 72% of patients with <z:e sem="disease" ids="C0868908" disease_type="Disease or Syndrome" abbrv="">pancolitis</z:e> by the treatment of <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> (<z:chebi fb="0" ids="6775">5-ASA</z:chebi>) (2-3 gr/day) + <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> (1 mg/kg/day) +/- (for maintenance of remission) <z:chebi fb="2" ids="2948">azathioprine</z:chebi> (<z:chebi fb="39" ids="10110">AZT</z:chebi>) (1.5-2 mg/kg/day); 3.7 months in 72% of left-sided <z:hpo ids='HP_0002583'>colitis</z:hpo> by <z:chebi fb="0" ids="6775">5-ASA</z:chebi> +/- <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> enemas +/- <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> (1 mg/kg/day) +/- (for maintenance of remission) <z:chebi fb="39" ids="10110">AZT</z:chebi> (1.5-2 mg/kg/day) and 3.7 months in 62.5% of patients with distal <z:hpo ids='HP_0002583'>colitis</z:hpo> by <z:chebi fb="0" ids="6775">5-ASA</z:chebi> (p.o. +/- enema) +/- <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> enemas </plain></SENT>
<SENT sid="8" pm="."><plain>Colectomy was performed on 7 patients refractory to these treatments </plain></SENT>
<SENT sid="9" pm="."><plain>Six patients (4 of them had <z:e sem="disease" ids="C0868908" disease_type="Disease or Syndrome" abbrv="">pancolitis</z:e>) were treated with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> (Cys) (4 mg/kg/day, p.o.) </plain></SENT>
<SENT sid="10" pm="."><plain>Only one patient, a non-responder to Cys therapy, had colectomy </plain></SENT>
<SENT sid="11" pm="."><plain>The mean remission time was 4.7 months in 80.6% of patients with extraintestinal involvement and 3.2 months in 71.2% of patients without extraintestinal involvement (P=0.002) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Medical therapy was generally enough for the treatment </plain></SENT>
<SENT sid="13" pm="."><plain>Cys and/or surgery can be another choice for the patients that do not respond to the medical therapy </plain></SENT>
<SENT sid="14" pm="."><plain>Extraintestinal manifestations do not change the remission rate, but prolong the time to catch remission </plain></SENT>
</text></document>